**Background and Significance**: 

In this study we will determine incidence rates and modifiable risk factors of infectious outcomes and medication adverse events in dermatomyositis patients through the OHDSI Community.

**Study Aims**: 

**Study Description**: 

* **Population**: 

* **Comparators**:
  
* **Outcomes**:
  
* **Design**: 

* **Timeframe**: 
